Entact Bio

About

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

Watertown,Massachusetts,United States
11 - 50
https://entactbio.com

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $81M
Industries: Biopharma,Biotechnology,Life Science,Medical
Founded date: Jan 1, 2019
Number Of Employee: 11 - 50
Operating Status: Active

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed to create enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

$81M

Entact Bio has raised a total of $81M in funding over 2 rounds. Their latest funding was raised on Dec 6, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 6, 2022	Series A	$81M	9	Qiming Venture Partners USA venBio Partners	—	Detail

Investments

Number of Investments

Number of Lead Investments

1

0

Entact Bio has made 1 investments. Their most recent investment was on Sep 20, 2022, when Tres raised $7.60M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Sep 20, 2022 Tres	Seed	$7.60M	Accounting	—

Investors

Number of Lead Investors

Number of Investors

2

9

Entact Bio is funded by 9 investors. Qiming Venture Partners USA and venBio Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
Qiming Venture Partners USA	Yes	Series A
venBio Partners	Yes	Series A
4BIO Capital	—	Series A
Abingworth	—	Series A
Arkin Bio Ventures	—	Series A
Brandon Capital Partners	—	Series A
Janus Henderson Investors	—	Series A
Logos Capital	—	Series A
Surveyor Capital	—	Series A